Načítá se...
Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases
OBJECTIVES: To identify the clinical outcomes of mRCC patients with PM treated with either pazopanib or sunitinib and assess whether PM is an independent prognostic variable in the current therapeutic environment. PATIENTS AND METHODS: Retrospective review of mRCC patients in an outpatient clinic wa...
Uloženo v:
| Vydáno v: | BJU Int |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4666814/ https://ncbi.nlm.nih.gov/pubmed/26032863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.13185 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|